Free Trial
NYSE:CHE

Chemed (CHE) Stock Price, News & Analysis

Chemed logo
$434.43 +8.22 (+1.93%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$432.44 -1.98 (-0.46%)
As of 05/15/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Chemed Stock (NYSE:CHE)

Advanced

Key Stats

Today's Range
$422.31
$435.25
50-Day Range
$368.42
$434.43
52-Week Range
$365.20
$583.96
Volume
268,840 shs
Average Volume
276,459 shs
Market Capitalization
$5.76 billion
P/E Ratio
23.67
Dividend Yield
0.55%
Price Target
$501.50
Consensus Rating
Hold

Company Overview

Chemed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

CHE MarketRank™: 

Chemed scored higher than 84% of companies evaluated by MarketBeat, and ranked 102nd out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemed has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Chemed has a consensus price target of $501.50, representing about 15.4% upside from its current price of $434.43.

  • Amount of Analyst Coverage

    Chemed has only been the subject of 4 research reports in the past 90 days.

  • Read more about Chemed's stock forecast and price target.
  • Earnings Growth

    Earnings for Chemed are expected to grow by 14.26% in the coming year, from $22.30 to $25.48 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemed is 23.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.80.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemed is 23.67, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.66.

  • Price to Earnings Growth Ratio

    Chemed has a PEG Ratio of 1.63. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Chemed has a P/B Ratio of 6.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemed's valuation and earnings.
  • Percentage of Shares Shorted

    4.09% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 1.69, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 21.99%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Chemed has a dividend yield of 0.55%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemed has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Chemed is 13.08%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chemed will have a dividend payout ratio of 9.42% next year. This indicates that Chemed will be able to sustain or increase its dividend.

  • Read more about Chemed's dividend.
  • News Sentiment

    Chemed has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Chemed this week, compared to 4 articles on an average week.
  • Search Interest

    Only 2 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Chemed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,648,620.00 in company stock.

  • Percentage Held by Insiders

    3.33% of the stock of Chemed is held by insiders.

  • Percentage Held by Institutions

    95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemed's insider trading history.
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHE Stock News Headlines

I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
See More Headlines

CHE Stock Analysis - Frequently Asked Questions

Chemed's stock was trading at $427.86 at the beginning of the year. Since then, CHE stock has increased by 1.5% and is now trading at $434.4290.

Chemed Corporation (NYSE:CHE) posted its quarterly earnings results on Thursday, April, 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.30 by $0.35. Chemed's revenue for the quarter was up 1.6% compared to the same quarter last year.
Read the conference call transcript
.

Chemed's top institutional investors include Epoch Investment Partners Inc. (1.88%), Dimensional Fund Advisors LP (1.87%), First Trust Advisors LP (1.78%) and Boston Trust Walden Corp (1.40%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Andrea R Lindell, George J Walsh III, Patrick P Grace, Michael D Witzeman, Brian C Judkins and Nicholas Michael Westfall.
View institutional ownership trends
.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Record date for 3/13 Dividend
2/23/2026
Ex-Dividend for 3/13 Dividend
2/23/2026
Dividend Payable
3/13/2026
Last Earnings
4/23/2026
Today
5/17/2026
RBC Capital Markets Global Healthcare Conference 2026
5/20/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NYSE:CHE
CIK
19584
Employees
15,811
Year Founded
1970

Price Target and Rating

High Price Target
$595.00
Low Price Target
$436.00
Potential Upside/Downside
+15.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$18.35
Trailing P/E Ratio
23.67
Forward P/E Ratio
19.48
P/E Growth
1.63
Net Income
$265.24 million
Net Margins
10.23%
Pretax Margin
13.73%
Return on Equity
27.18%
Return on Assets
17.38%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
0.85
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$2.53 billion
Price / Sales
2.28
Cash Flow
$24.66 per share
Price / Cash Flow
17.62
Book Value
$63.88 per share
Price / Book
6.80

Miscellaneous

Outstanding Shares
13,270,000
Free Float
12,832,000
Market Cap
$5.76 billion
Optionable
Optionable
Beta
0.54

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:CHE) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners